Skip to main content
SpringerLink
Log in

Oral ferric pyrophosphate cost saving for iron deficiency

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. 2017 euros

Reference

  • Darba J, et al. Budget Impact Analysis of Oral Fisiogen Ferro Forte((R)) versus Intravenous Iron for the Management of Iron Deficiency in Chronic Kidney Disease in Spain. Clinical Drug Investigation : 22 Jun 2018. Available from: URL: http://doi.org/10.1007/s40261-018-0666-9

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Oral ferric pyrophosphate cost saving for iron deficiency. PharmacoEcon Outcomes News 807, 26 (2018). https://doi.org/10.1007/s40274-018-5105-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-018-5105-x

Search

Navigation